United States · FDA National Drug Code directory
hydroxyzine pamoate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0185-0674_c94e4245-cac4-4d59-b3a3-64a09b67c2e9
- Product NDC
- 0185-0674
- Form
- CAPSULE
- Composition / generic term
- hydroxyzine pamoate
- Labeler
- Sandoz Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19811214
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROXYZINE PAMOATE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (0185-0674-01) · 0185-0674-01
- 500 CAPSULE in 1 BOTTLE (0185-0674-05) · 0185-0674-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →